UnitedHealth Group Inc (NYSE:UNH) – Stock analysts at Oppenheimer increased their Q2 2018 earnings per share (EPS) estimates for UnitedHealth Group in a note issued to investors on Tuesday. Oppenheimer analyst M. Wiederhorn now forecasts that the healthcare conglomerate will post earnings of $2.98 per share for the quarter, up from their prior forecast of $2.67. Oppenheimer has a “Outperform” rating and a $240.00 price target on the stock.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, January 16th. The healthcare conglomerate reported $2.59 earnings per share for the quarter, topping the consensus estimate of $2.50 by $0.09. The company had revenue of $52.06 billion during the quarter, compared to analysts’ expectations of $51.57 billion. UnitedHealth Group had a net margin of 5.25% and a return on equity of 21.29%. The business’s quarterly revenue was up 9.5% on a year-over-year basis. During the same period last year, the business earned $2.11 EPS.

UNH has been the subject of several other reports. Goldman Sachs Group initiated coverage on shares of UnitedHealth Group in a research note on Wednesday, January 3rd. They set a “buy” rating and a $269.00 price target for the company. Zacks Investment Research cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Tuesday, September 26th. Morgan Stanley raised their price target on shares of UnitedHealth Group from $215.00 to $235.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 18th. ValuEngine cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Thursday, October 5th. Finally, Leerink Swann reaffirmed a “buy” rating and set a $240.00 price target (up from $225.00) on shares of UnitedHealth Group in a research note on Wednesday, October 18th. Three research analysts have rated the stock with a hold rating and twenty-five have issued a buy rating to the stock. UnitedHealth Group currently has an average rating of “Buy” and a consensus target price of $241.30.

Shares of UnitedHealth Group (NYSE:UNH) traded up $4.73 on Thursday, hitting $243.16. 6,234,000 shares of the stock traded hands, compared to its average volume of 3,634,767. The company has a market cap of $234,070.00, a PE ratio of 22.70, a P/E/G ratio of 1.45 and a beta of 0.66. UnitedHealth Group has a one year low of $156.49 and a one year high of $243.90. The company has a quick ratio of 0.70, a current ratio of 0.73 and a debt-to-equity ratio of 0.58.

A number of hedge funds have recently added to or reduced their stakes in the business. Regal Wealth Group Inc. boosted its position in UnitedHealth Group by 0.4% during the second quarter. Regal Wealth Group Inc. now owns 746 shares of the healthcare conglomerate’s stock worth $138,000 after purchasing an additional 3 shares during the period. Jackson Grant Investment Advisers Inc. boosted its position in UnitedHealth Group by 0.4% during the second quarter. Jackson Grant Investment Advisers Inc. now owns 1,101 shares of the healthcare conglomerate’s stock worth $204,000 after purchasing an additional 4 shares during the period. RNC Capital Management LLC boosted its position in UnitedHealth Group by 0.7% during the second quarter. RNC Capital Management LLC now owns 1,940 shares of the healthcare conglomerate’s stock worth $360,000 after purchasing an additional 13 shares during the period. Highland Private Wealth Management boosted its position in UnitedHealth Group by 0.4% during the second quarter. Highland Private Wealth Management now owns 3,199 shares of the healthcare conglomerate’s stock worth $593,000 after purchasing an additional 13 shares during the period. Finally, Flagship Harbor Advisors LLC lifted its holdings in shares of UnitedHealth Group by 0.3% during the second quarter. Flagship Harbor Advisors LLC now owns 5,028 shares of the healthcare conglomerate’s stock worth $939,000 after buying an additional 15 shares in the last quarter. 86.09% of the stock is owned by hedge funds and other institutional investors.

In other UnitedHealth Group news, Director Kenneth Irwin Shine sold 457 shares of UnitedHealth Group stock in a transaction on Tuesday, November 14th. The shares were sold at an average price of $211.03, for a total transaction of $96,440.71. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Gail R. Wilensky sold 5,600 shares of UnitedHealth Group stock in a transaction on Wednesday, November 29th. The stock was sold at an average price of $223.31, for a total transaction of $1,250,536.00. Following the transaction, the director now directly owns 61,137 shares of the company’s stock, valued at $13,652,503.47. The disclosure for this sale can be found here. Insiders sold 33,655 shares of company stock valued at $7,469,083 over the last three months. 0.89% of the stock is owned by company insiders.

TRADEMARK VIOLATION WARNING: “Oppenheimer Equities Analysts Raise Earnings Estimates for UnitedHealth Group Inc (UNH)” was originally posted by Daily Political and is the sole property of of Daily Political. If you are accessing this piece on another publication, it was illegally copied and republished in violation of U.S. and international trademark & copyright law. The legal version of this piece can be viewed at https://www.dailypolitical.com/2018/01/19/oppenheimer-equities-analysts-raise-earnings-estimates-for-unitedhealth-group-inc-unh.html.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Earnings History and Estimates for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.